The clearances expand the pipeline of listed offerings, signaling robust investor appetite and providing growth capital to mid‑size Indian firms. This diversification strengthens market depth and offers new opportunities for institutional and retail investors.
The recent SEBI observations mark a notable uptick in India’s primary market activity, as five companies from distinct sectors receive green lights to list. This batch of approvals reflects the regulator’s confidence in the quality of draft prospectuses and underscores a broader trend of mid‑cap firms seeking public capital to fund expansion. By clearing both fresh issues and offer‑for‑sale components, SEBI facilitates not only new fundraising but also secondary liquidity for existing shareholders, a combination that can attract a wider investor base.
Each company targets specific growth levers with the capital raised. Premier Industrial plans to channel funds into a new wire‑manufacturing plant and expand its existing facilities in Maharashtra, positioning itself to meet rising demand in the infrastructure supply chain. Duroflex, a leading mattress and sleep‑solutions brand, aims to bolster its retail footprint and digital channels through a Rs 184 crore fresh issue. Meanwhile, Virupaksha Organics’ sizable Rs 740 crore offering signals aggressive scaling in the pharma space, and Hexagon Nutrition’s pure OFS provides an exit route for its founding family while keeping the business operationally focused.
For investors, the diversified nature of these listings offers exposure to sectors poised for growth amid India’s economic expansion. The mix of fresh capital and OFS structures can balance valuation discipline with liquidity, appealing to both long‑term growth seekers and those looking for near‑term trading opportunities. As the market digests these upcoming IPOs, heightened activity could reinforce confidence in the Indian equity ecosystem, potentially spurring further listings and deepening the capital market’s role in financing the country’s industrial and consumer‑goods ambitions.
Sebi granted observation letters to Duroflex Limited, Premier Industrial Corporation, Virupaksha Organics, Hexagon Nutrition and Om Power Transmission, clearing them to launch their initial public offerings. The firms span manufacturing, pharma, nutrition, power EPC and sleep solutions, with fresh issue and offer‑for‑sale components outlined in their prospectuses.
Source: The Economic Times – Markets
Duroflex, Premier Industrial Corporation, 3 more companies get Sebi nod to launch IPO
By Shivendra Kumar, ETMarkets.com
Last Updated: Feb 13 2026, 06:47 PM IST
Sebi granted IPO clearance to five firms across manufacturing, pharma, nutrition, power EPC and sleep solutions, paving the way for fresh fundraising and stake sales.
Premier Industrial Corporation, Virupaksha Organics, Hexagon Nutrition, Om Power Transmission and Duroflex have secured approval from the Securities and Exchange Board of India (Sebi) to proceed with their initial public offerings (IPOs). All five companies received Sebi’s observation during the week.
In IPO parlance, Sebi’s “observation” refers to the formal comments or clearance issued by the regulator on a company’s draft IPO documents.
Premier Industrial Corporation’s IPO will be a mix of fresh issue and an offer‑for‑sale (OFS). The company received Sebi’s observation letter on 10 February.
Issue size: 2.79 crore equity shares will be off‑loaded by the company – up to 2.25 crore as a fresh issue and up to 54 lakh as an OFS.
Selling shareholders: Arvind Chhotalal Morzaria, Dilip Chhotalal Morzaria, Subhash Chhotalal Morzaria, Lalit Navinchandra Morzaria and Nirmala Navinchandra Morzaria.
Use of proceeds: financing capital‑expenditure for a new wire‑manufacturing facility in Raigad, Maharashtra, expanding the existing manufacturing facility at the Wada Unit in Palghar, Maharashtra, working‑capital requirements and general corporate purposes.
Unistone Capital Private Limited is the sole Book‑Running Lead Manager (BRLM) to the issue.
Duroflex IPO will be a mix of fresh issue and an OFS. The company received Sebi’s observation letter on 12 February.
Issue composition: a fresh issue of equity shares aggregating up to Rs 184 crore and an OFS of up to 2.25 crore equity shares by promoters and existing investors.
Company profile: Duroflex Limited is a leading sleep‑and‑comfort solutions provider and is among the top three mattress companies in India by market share. It operates across mattresses, foam, furniture, pillows, accessories and other bedding products under brands such as Duroflex, Sleepyhead and Perfect Rest. As of 30 June 2025, Duroflex has 73 company‑owned/operated stores, over 5,576 general‑trade stores and a strong digital presence, serving a pan‑India customer base.
Virupaksha Organics IPO will be entirely a fresh issue worth Rs 740 crore, according to the Draft Red Herring Prospectus (DRHP) filed by the company. The research‑driven Indian pharmaceutical company received Sebi’s nod on 12 February.
Promoters: Chandra Mouliswar Reddy Gangavaram, Balasubba Reddy, Mamilla Chandrasekhar Reddy Gangavaram, Vedavathi Gangavaram, Kondapalli Sandeep Reddy, Kotla S Uuraj Redy, Mamilla Nagarjun Reddy, Gangavaram Sri Lakshmi and G Sri Vidya.
BRLMs: Axis Capital Limited and SBI Capital Markets Limited.
Registrar: Kfin Technologies Limited.
The public issue of Hexagon Nutrition will be entirely an OFS. The company received Sebi’s clearance on 10 February.
Promoters/off‑load: Arun Purushottam Kelkar, Subhash Purushottam Kelkar, Nutan Subhash Kelkar and Aditya Kelkar will together off‑load up to 30,859,704 equity shares.
Business: The research‑driven nutrition company develops and manufactures micronutrient premixes, branded wellness and clinical nutrition products, therapeutic formulations and ready‑to‑use foods.
Lead managers: Cumulative Capital Private Limited and Catalyst Capital Partners Private Limited.
Registrar: Kfin Technologies.
Om Power Transmission IPO will be a mix of fresh issue and an OFS. The company received the observation on 12 February.
Disclaimer: The recommendations, suggestions, views, and opinions given by the experts are their own. These do not represent the views of The Economic Times.
Comments
Want to join the conversation?
Loading comments...